Unlocking the future of neurodegeneration research
In this piece by Dr. Felix Spira, Senior Manager for Hardware Engineering & Applications at Molecular Devices, he outlines how the tandem advancements of human-derived brain organoids and automated culturing platforms are unlocking new frontiers in neurodegeneration research. The article highlights how organoids offer human-relevant disease models, and how automation brings the scale and reproducibility needed for high-throughput drug discovery, together setting the stage for the next wave of breakthroughs in therapies for conditions like Alzheimer’s and Parkinson’s.